Meet Marion Heckenroth, from our Evionnaz site’s Analytical Department, where she’s been making an impact since 2012! Working at Siegfried gives her a strong sense of purpose as she contributes to improving people’s lives, all while enjoying a role that brings something new every day. Want to hear more about Marion’s journey at Siegfried? Discover her story here https://lnkd.in/d_tDbwSd #EmployeeAmbassador #Dedication #Passion #CareerGrowth #SafeDrugs #AnalyticalDevelopment
Siegfried
Arzneimittelherstellung
Zofingen, Aargau 30.293 Follower:innen
Expect more
Info
Expect more with Siegfried as your preferred partner. Siegfried is a preferred manufacturing and service partner in the global pharmaceutical industry. Our company is looking back on more than 150 years of unmatched quality and combines both chemistry and pharmaceutics under one roof. We develop and manufacture active pharmaceutical ingredients for pharmaceutical clients with R&D programs, related intermediates and controlled substances. Siegfried also offers development and production of finished dosage forms, including sterile fillings. Approximately 3600 dedicated employees in Switzerland, Germany, France, Spain, Malta, China and the USA establish innovative and integrated solutions for our customers that bring a significant added value.
- Website
-
http://www.siegfried.ch
Externer Link zu Siegfried
- Branche
- Arzneimittelherstellung
- Größe
- 1.001–5.000 Beschäftigte
- Hauptsitz
- Zofingen, Aargau
- Art
- Kapitalgesellschaft (AG, GmbH, UG etc.)
- Gegründet
- 1873
- Spezialgebiete
- Formulation Development, Analytical Development, Solid Dosage Forms, Parenterals (vials, ampoules, cartridges, syringes), Ophtalmics (liquids and semisolids), API, Active Pharmaceutical Ingredient, Exclusive Synthesis, High Potency, Intermediates, Sterile Filling, biologics finished dosage forms und spray drying
Orte
Beschäftigte von Siegfried
Updates
-
We were pleased to host Cantonal Councillor Dieter Egli and a delegation from his management team last week at our headquarters in Zofingen. We discussed our operations and current market challenges.
Zu Besuch bei Siegfried in Zofingen: Regierungsrat Dieter Egli konnte sich mit einer Delegation aus seinem Führungsteam im Gespräch mit dem CEO Marcel Imwinkelried, Henrik Krüpper, Fredy Karlen und Luca Dalla Torre letzte Woche ein Bild davon machen, wie das weltweit tätige Unternehmen mit Hauptsitz in Zofingen agiert und was die aktuellen Herausforderungen im Markt sind. Siegfried blickt auf eine über 150-jährige Geschichte zurück und ist inzwischen an 13 Standorten auf drei Kontinenten tätig. Das Aargauer Unternehmen bietet die Auftragsentwicklung und -herstellung von pharmazeutischen Wirkstoffen, Zwischenprodukten und fertigen Darreichungsformen an (Contract Development and Manufacturing Organisation (CDMO)). Weltweit beschäftigt Siegfried rund 3'700 Mitarbeitende, am Hauptsitz und Produktionsstandort in Zofingen arbeiten rund 700 Mitarbeitende. #Siegfried #Aargau #AargauerWirtschaft #Standortförderung
-
-
Siegfried holds its Capital Markets Day 2024 today at its site in Barberà del Vallès (Spain). At this event, Marcel Imwinkelried, CEO since September 1, 2024, and CFO Reto Suter will provide deeper insight into Siegfried's updated strategy EVOLVE+ https://lnkd.in/dj9sV6Xi #MediaRelease #Announcement #Strategy #Evolve #CapitalMarketsDay
-
-
We’re proud to announce that our site in Malta has been awarded the prestigious EcoVadis Gold Medal for the first time this year! This recognition highlights the substantial improvements and the unwavering dedication of our team in driving positive environmental and sustainability initiatives through key site projects. A big thank you to everyone involved in making a difference for a more sustainable future! #Sustainability #EcoVadis #GoldMedal #ESG #SustainableBusiness #GreenFuture
-
-
Drug development is costly and risky, with less than 10% of candidates reaching commercialization. Ranjit Verma shares key strategies to accelerate the path to clinical trials. At Siegfried's Acceleration Hub, we provide comprehensive support for customers in both preclinical and clinical development, helping to speed up drug substance manufacturing and bring innovative treatments to market faster.
-
Today on #WorldSightDay, we raise awareness about vision impairment, blindness, and the importance of regular eye exams and access to eye care for all. At Siegfried, we're dedicated to improving eye health. Our Siegfried El Masnou site, our largest facility for ophthalmic products, produces treatments that enhance the quality of life for millions of patients worldwide. Learn more about our ophthalmic capabilities at El Masnou: https://lnkd.in/g8euesGw #WorldSightDay #LoveYourEyes #IAPB
-
-
Day 2 of #CPHIMilano is in full swing! Today, Klaus Stingl shares valuable insights on the key trends shaping the pharmaceutical industry and how Siegfried is helping customers navigate increasing complexity. Stop by Booth 5B17 to learn how we can support your journey in tackling industry challenges. #CPHIMilano #PharmaInnovation #CustomerInsights #PharmaSolutions
-
An insightful first day at #CPHIMilano has come to a close! Marianne Spaene shares insights from customer conversations on fill-finish services, touching on the need for quality, reliability, and agility. We are looking forward to more great discussions over the next two days. Stop by our booth, 5B17 to explore how we can support your fill-finish needs! #CPHIMilano #FillFinish #CustomerInsights
-
We are putting the finishing touches on our #CPHIMilano booth in preparation to welcome you tomorrow. Come visit us at booth 5B17. #AtTheHeartOfPharma #CDMO #Expertise
-